16-hydroxycleroda-3,13(14)-dien-15,16-olide and Neoplasms

16-hydroxycleroda-3,13(14)-dien-15,16-olide has been researched along with Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chan, WL; Chang, JG; Chang, WH; Lee, CC; Lin, YH; Wu, YC	1

Other Studies

1 other study(ies) available for 16-hydroxycleroda-3,13(14)-dien-15,16-olide and Neoplasms

Article	Year
16-Hydroxycleroda-3,13-dien-15,16-olide deregulates PI3K and Aurora B activities that involve in cancer cell apoptosis. Toxicology, 2011, Jul-11, Volume: 285, Issue:1-2 Topics: Antineoplastic Agents; Apoptosis; Aurora Kinase B; Aurora Kinases; Benzamides; Cell Cycle; Cell Line, Tumor; Cell Survival; Diterpenes; DNA Damage; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Imatinib Mesylate; Neoplasms; Phosphoinositide-3 Kinase Inhibitors; Piperazines; Protein Serine-Threonine Kinases; Pyrimidines; Signal Transduction	2011

Article

Year

16-Hydroxycleroda-3,13-dien-15,16-olide deregulates PI3K and Aurora B activities that involve in cancer cell apoptosis.

Toxicology, 2011, Jul-11, Volume: 285, Issue:1-2

Topics: Antineoplastic Agents; Apoptosis; Aurora Kinase B; Aurora Kinases; Benzamides; Cell Cycle; Cell Line, Tumor; Cell Survival; Diterpenes; DNA Damage; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Imatinib Mesylate; Neoplasms; Phosphoinositide-3 Kinase Inhibitors; Piperazines; Protein Serine-Threonine Kinases; Pyrimidines; Signal Transduction

2011